US Stock MarketDetailed Quotes
PRTG Portage Biotech
- 4.590
- -0.380-7.65%
Close Nov 8 16:00 ET
4.81MMarket Cap-63P/E (TTM)
5.145High4.590Low37.04KVolume4.890Open4.970Pre Close175.74KTurnover6.22%Turnover RatioLossP/E (Static)1.05MShares40.80052wk High1.92P/B2.73MFloat Cap2.08052wk Low--Dividend TTM595.21KShs Float899.526Historical High--Div YieldTTM11.17%Amplitude2.080Historical Low4.745Avg Price1Lot Size
About Portage Biotech Company
Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.
Company Profile
SymbolPRTG
Company NamePortage Biotech
Listing DateFeb 25, 2021
Founded1973
CEODr. Ian B. Walters, M.D.
MarketNASDAQ
Employees7
Fiscal Year Ends03-31
AddressClarence Thomas Building
CityRoad Town
ProvinceTortola
CountryVirgin Islands (British)
Zip CodeVG1110
Phone1-203-221-7378
Company Executives
- Name
- Position
- Salary
- Dr. Ian B. Walters, M.D.
- Chief Executive Officer and Chairman of the Board
- 642.70K
- Robert Kramer
- Chief Scientific Officer
- 185.89K
- Brian Wiley
- Chief Business Officer
- 155.42K
- Allan Lee Shaw
- Chief Financial Officer
- 518.21K
- Dr. Jean-Christophe Renondin, M.D.
- Director
- --
- Dr. Justin Stebbing
- Director
- --
- James Mellon
- Independent Director
- 86.98K
- Steven M. Mintz
- Independent Director
- 96.48K
- Dr. Gregory Hugh Bailey, M.D.
- Lead Independent Director
- 103.98K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data